MCKEE KELLY T. JR. (Chief Medical Officer) purchased 24.1% of their position (6.94K shares) of GEOVAX LABS, INC. on the open market
Open‑market purchase worth $2.5K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/26/2023ACC: 0001437749-23-035306
Officer· Chief Medical Officer
Since Jan 2022
+6.94K
Net shares
Net buyer
$2.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6.94K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.94K
Price / share
$0.36
Trade value
$2.50K
% of position
24.1%
12/22/2023
28.84K→35.78K
Total
Net shares
+6.94K
Net value
$2.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2023 | P · Purchase | +6.94K | $0.36 | $2.50K | 24.1% | 28.84K | 35.78K |
| Total | +6.94K | $2.50K | ||||||
Derivative Transactions0
No derivative transactions reported